Preparation and characterization of solid dispersions of dipyridamole with a carrier "copolyvidonum Plasdone®S-630"

Drug Development and Industrial Pharmacy

Volumn 33, Issue 8, 2007, Pages 888-899

  Chen, Shengjun ^a   Zhu, Jiabi ^a   Ma, Fengqin ^a   Fang, Qun ^a   Li, Yinghuan ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Beijing Sinovation Pharmtech Development Co Ltd   (China)

Author keywords

Compressibility; Copolyvidonum; Dipyridamole; Hydroscopicity; PVP; Solid dispersion

Indexed keywords

DIPYRIDAMOLE; DRUG CARRIER; HYDROGEN; POVIDONE;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG STABILITY; DRUG SYNTHESIS; EVAPORATION; HYDROGEN BOND; INFRARED SPECTROSCOPY; POLARIZATION MICROSCOPY; SOLID STATE; X RAY DIFFRACTION;

ACETATES; CALORIMETRY, DIFFERENTIAL SCANNING; DIPYRIDAMOLE; DRUG CARRIERS; MICROSCOPY, POLARIZATION; PLATELET AGGREGATION INHIBITORS; POVIDONE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 34548295584     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701199209     Document Type: Article

References (26)

1. Ahlneck, C., & Zografi, G. (1990). The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int. J. Pharm., 62, 87-95.
2. Carr, R. L. (1965). Evaluating flow properties of solids. Chem. Eng. 72, 163-168.
3. Carstensen, J. T. (1974). Stability of solids and solid dosage forms. J. Pharm. Sci. 63, 1-14.
4. Chan, L. W., Ong, K. T., & Heng, P. W. S. (2005). Novel film modifiers to alter the physical properties of composite ethylcellulose films. Pharm. Res., 22, 476-489.
5. Chokshi, R. J., Sandhu, H. K., Iyer R. M., Shah, N. H., Malick, A. W., & Zia, H. (2005). Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion process as a means to manufacture solid dispersion/solution. J. Pharm. Sci., 94, 2463-2474.
6. Ford, J. L. (1986). The current status of solid dispersions. Pharm. Acta Helv., 61, 69-88.
7. Ford, J. L., & Rubenstein, M. H. (1979). Ageing of indomethacin-polyethylene glycol 6000 solid dispersion. Pharm. Acta Helv., 54, 353 358.
8. Fujii, M., Okada, H., Shibata, Y., Teramachi, H., Kondoh, M., & Watanabe, Y. (2005). Preparation, characterization, and tableting of a solid dispersion of indomethacin with crospovidone. Int. J. Pharm., 293, 145-153.
9. Ghebremeskel, A. N., Vemavarapu, C. V., & Lodaya M. (2006). Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: Stability testing of selected solid dispersions. 83, 1928-1936.
10. Kondo, N., Iwao, T., Hirai, K., Fukuda, M., Yamanouchi, K., Yokoyama, K., Miyaji, M., Ishihara, Y., Kon, K., & Ogawa, Y. (1994). Improved oral absorption of enteric coprecipitates of a poorly soluble drug. J. Pharm. Sci., 83, 566-70.
11. Kontny, M. J., Grandolfi, G. P., & Zogragi, G. (1987). Water sorption of water-soluble substances: Studies of crystalline solids below their critical relative humidities. Pharm. Res., 4, 104-112.
12. Leuner, C., & Dressman, J. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm., 50, 47-60.
13. Marín, M. T., Margarit, M. V., & Salcedo, G. E. (2002). Characterization and solubility study of SDs of flunarizine and polyvinylpyrrolidone. Farmaco. 57, 723-727.
14. Moneghini, M., Carcano, A., Zingone, G., & Perissutti, B. (1998). Studies in dissolution enhancement of atenolol, Part I. Int. J. Pharm., 175, 177-183.
15. Moore J. W., & Flanner H. H. (1996). Mathematical comparison of dissolution profiles. Pharm. Tech., 20, 64-74.
16. Moroni, A. (2001). A novel copovidone binder for drug granulation and direct-compression tabletting. Pharm. Technol., 24, 8-12.
17. Peh, K. K., & Wong, C. F. (2000). Application of Similarity Factor in Development of Controlled-Release Diltiazem Tablet. Drug Dev. Ind. Pharm., 26, 723-730.
18. Porubcan, L. S., Serna, C. J., White, J. L., & Hem, S. L. (1978). Mechanism of adsorption of clindamycin and tetracycline by montmorillonite. J. Pharm. Sci., 67, 1081-1087.
19. Sekikawa, H., Nakano, M., & Arita, T. (1978). Inhibitory effect of polyvinylpyrrolidone on the crystallization of drugs. Chem. Pharm. Bull., 26, 118-126.
20. Sethia, S., & Squillante, E. (2004). Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int. J. Pharm., 272, 1-10.
21. Tantishaiyakul, V., Kaewnopparat, N., & Ingkatawornwong, S. (1996). Properties of SDs of piroxicam in polyvinylpyrrolidone K-30. Int. J. Pharm., 143, 59-66.
22. Taylor, L. S., & Zografi G. (1997). Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res., 14, 1691-1698.
23. Van den Mooter, G., Augustijns, P., Blaton, N., & Kinget, R. (1998). Physicochemical characterization of SDs of temazepam with polyethylene glycol 6000 and PVP K30. Int. J. Pharm., 164, 67-80.
24. Van den Mooter, G., Weuts, I., De Ridder, T., & Blaton N. (2006). Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs. Int J Pharm., 316, 1-6.
25. Wadke, D. A., Serajuddin, A. T. M., & Jacobson, H. (1989). Preformulation testing. In Lieberman, H. A., Lachman, L., Schwartz, J. B. (eds.), Pharmaceutical Dosage forms: Tablets (Vol. 1; pp. 1-73). New York: Marcel Dekker, Inc.
26. Zingone, G., & Rubessa, F. (1994). Release of carbamazepine from solid dispersions with polyvinylpyrrolidone/vinylacetate copolymer (PVP/VA). S.T.P. Pharm. Sci., 4, 122-127.